Literature DB >> 6364998

Synovial protease/inhibitor ratios in erosive and nonerosive arthropathies.

M H Pritchard.   

Abstract

Although rheumatoid joint fluids contain numerous polymorphs capable of secreting neutral proteases known to be able to digest cartilage, the high level of inhibitors (mainly alpha 1-antitrypsin and alpha 2-macroglobulin) has always been considered to be more than sufficient to inhibit their activity completely. Consequently little interest has been paid to the potential role of these enzymes in cartilage damage. Four arthropathies of different erosive potential are here compared: spondyloarthropathies, rheumatoid arthritis with and without gold or D-penicillamine therapy, and septic arthritis. The synovial concentration of the inhibitors alpha 1-antitrypsin and alpha 2-macroglobulin has been compared with the polymorph enzyme output, as measured by beta-glucuronidase. Total haemolytic complement, white cell count, and C-reactive protein have also been measured in the joint fluid. The range of white cell count and inhibitors was the same in all 4 groups, while the enzyme output varied substantially from low levels in the spondyloarthropathies to very high levels in the septic joints. The higher the erosive potential of the disease, therefore, the more disadvantageous is the inhibitor/enzyme ratio. It is also pointed out that cartilage has physiochemical properties which facilitate and enhance polymorph enzyme output while severely curtailing the activity of the inhibitors. The observation that synovial fluid is inhibitory in vitro may therefore bear little relationship to the situation at the cartilage surface in vivo.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6364998      PMCID: PMC1001219          DOI: 10.1136/ard.43.1.50

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  Mechanism of inhibition of porcine elastase by human alpha-1-antitrypsin.

Authors:  H L James; A B Cohen
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

Review 2.  Articular damage in arthritis and its control.

Authors:  J T Dingle
Journal:  Ann Intern Med       Date:  1978-06       Impact factor: 25.391

Review 3.  The immunopathology of joint inflammation in rheumatoid arthritis.

Authors:  N J Zvaifler
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

4.  Electroimmuno assay.

Authors:  C B Laurell
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

5.  Interaction of cells with immune complexes: adherence, release of constituents, and tissue injury.

Authors:  P M Henson
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

6.  Interaction of polymorphonuclear leukocytes with immune complexes trapped in joint collagenous tissues.

Authors:  K Ugai; M Ziff; H E Jasin
Journal:  Arthritis Rheum       Date:  1979-04

7.  Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues.

Authors:  T D Cooke; E R Hurd; H E Jasin; J Bienenstock; M Ziff
Journal:  Arthritis Rheum       Date:  1975 Nov-Dec

8.  Protease inhibitors in inflammatory synovial effusions.

Authors:  N M Hadler; A M Johnson; J K Spitznagel; R J Quinet
Journal:  Ann Rheum Dis       Date:  1981-02       Impact factor: 19.103

9.  Human serum beta-glucuronidase; its measurement and some of its properties.

Authors:  W H Fishman; K Kato; C L Anstiss; S Green
Journal:  Clin Chim Acta       Date:  1967-03       Impact factor: 3.786

10.  Release of cartilage mucopolysaccharide-degrading neutral protease from human leukocytes.

Authors:  A Oronsky; L Ignarro; R Perper
Journal:  J Exp Med       Date:  1973-08-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Kallikreins and kinins: mediators in inflammatory joint disease?

Authors:  K Worthy; C D Figueroa; P A Dieppe; K D Bhoola
Journal:  Int J Exp Pathol       Date:  1990-08       Impact factor: 1.925

2.  The relationship between cell-mediated immunity and cartilage degradation in antigen-induced arthritis in the rabbit.

Authors:  E R Pettipher; B Henderson
Journal:  Br J Exp Pathol       Date:  1988-02

3.  Interference of cartilage surface with interaction of granulocyte elastase with alpha 1-proteinase inhibitor. An in vitro model of enzyme inhibition in the joint space.

Authors:  H Burkhardt; M Kasten; S Rauls; E Rehkopf
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

4.  Polymorphonuclear granulocytes in rheumatic tissue destruction. VI. The occurrence of PMNs in menisci of patients with rheumatoid arthritis.

Authors:  W Mohr; B Pelster; D Wessinghage
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

5.  The role of cartilage canals in the pathogenesis of experimentally induced polyarthritis.

Authors:  R Denecke; G Trautwein; F J Kaup
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

6.  Degradation in vivo of articular cartilage in rheumatoid arthritis and juvenile chronic arthritis by cathepsin G and elastase from polymorphonuclear leukocytes.

Authors:  M Velvart; K Fehr
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

7.  Identification of α1-Antitrypsin as a Potential Candidate for Internal Control for Human Synovial Fluid in Western Blot.

Authors:  Shaowei Wang; Jingming Zhou; Xiaochun Wei; Pengcui Li; Kai Li; Dongming Wang; Fangyuan Wei; Jianzhong Zhang; Lei Wei
Journal:  Rheumatology (Sunnyvale)       Date:  2015-05-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.